Skip to content
Screener

Mesa Laboratories MLAB Q2 2026 earnings

Reported November 6, 2025 · After market close

Revenue$60.7MMiss by $296.3K
EPS$1.76Beat by $0.20
Revenue estimate$61.0M
EPS estimate$1.56

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$61.6M
EPS estimate$1.59

Financials

Q2 2026

Income statement

See full
Revenue$60.7M+5.0%
Net income$2.5M-27.8%

Balance sheet

See full
Cash & equivalents$20.4M-16.1%
Total debt$68.0M-59.8%
Total equity$178.5M+10.5%
Total assets$430.4M-5.2%

Cash flow

See full
Operating cash flow$8.2M+56.0%
CapEx$1.1M-38.9%
Free cash flow$7.1M+105%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$368.65M-47.4%
Enterprise value$416.21M-50.8%
P/S1.5×-1.6×

Profitability

See full
Net margin-0.6%-0.3pp
FCF margin15.2%-0.6pp

Returns & leverage

See full
Return on equity-0.9%-0.5pp
Debt / equity0.4×-0.7×
Current ratio2×+1.3×

Segments

By geography

See full
US$29.3M+4.4%
Other$26.1M+16.8%
CN$5.3M-28.1%

By segment

See full
Biopharmaceutical Development$13.9M—
Clinical Genomics$11.1M—

By product

See full
Consumables$33.4M—
Hardware And Software$16.1M—

FAQ

When did Mesa Laboratories report Q2 2026 earnings?
Mesa Laboratories (MLAB) reported Q2 2026 earnings on November 6, 2025 after market close.
What were Mesa Laboratories's Q2 2026 revenue and EPS?
Mesa Laboratories reported revenue of $60.7M and eps of $1.76 for Q2 2026.
Did Mesa Laboratories beat estimates in Q2 2026?
Revenue missed the consensus estimate of $61.0M by $296.3K. EPS beat the consensus estimate of $1.56 by $0.20.
How did Mesa Laboratories's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.0% from $57.8M a year earlier and eps declined 28.2% from $2.45.
Where can I find Mesa Laboratories's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000724004-25-000012) and the 10-Q periodic report (0000724004-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.